---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-007066"
form_type: "8-K"
ticker: "ASPC"
cik: "0001890361"
company_name: "ASPAC III Acquisition Corp."
filed_at: "2025-01-27T23:59:59+00:00"
generated_at: "2026-05-27T09:30:08.184284+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ASPAC III Acquisition Corp. announces $200M all-stock acquisition of Bioserica International

## Summary
- Agrees to acquire Bioserica International, a bio-based antimicrobial materials company, for $200M in stock at $10.00/share.
- Transaction structured as reincorporation merger of SPAC into new BVI company, then merger with Bioserica.
- Closing conditions include SEC registration effectiveness, SPAC shareholder approval, and Nasdaq listing.
- Termination right if audited financials not delivered by May 31, 2025.
- Agreement is subject to negotiation of definitive agreements; shares to be issued at $10.00 per Purchaser share.

## SEC filing metadata
- accession: 0001213900-25-007066
- form_type: 8-K
- ticker: ASPC
- cik: 0001890361
- company_name: ASPAC III Acquisition Corp.
- filed_at: 2025-01-27T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1890361/000121390025007066/0001213900-25-007066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1890361/000121390025007066/ea0228397-8k425_aspac3.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-007066
- JSON: https://secwatch.observer/filing/0001213900-25-007066.json
- Plain text: https://secwatch.observer/filing/0001213900-25-007066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.